{"id":"W2520297993","doi":"10.1002/jcph.828","title":"Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients With Chronic Heart Failure","year":2016,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"Surgical Specialties (Canada)","funders":"Bayer","keywords":"Tolerability; Medicine; Placebo; Agonist; Ejection fraction; Partial agonist; Heart failure; Adenosine; Anesthesia; Cardiology; Heart rate; Internal medicine; Blood pressure; Adverse effect; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008631776,0.0004494894,0.0009604082,0.0001913782,0.0003036944,0.0003408411,0.0001522888,0.0004706965,0.0007415388],"category_scores_gemma":[0.00152083,0.0001932239,0.0005584075,0.0001655457,0.0003461696,0.000326297,0.0001655244,0.0006721251,0.0001668406],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001867583,"about_ca_system_score_gemma":0.0002536664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003835401,"about_ca_topic_score_gemma":0.0005918621,"domain_scores_codex":[0.9996424,0.0001499991,0.00004693189,0.00005424971,0.00007158756,0.00003485204],"domain_scores_gemma":[0.9988248,0.0004209979,0.0003271448,0.00007107254,0.0001099252,0.000245993],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2978324,0.012162,0.3166412,0.001277836,0.001838947,0.00201699,0.001570883,0.001586193,0.1326592,0.0001413643,0.001026662,0.2312463],"study_design_scores_gemma":[0.02996494,0.3839079,0.572148,0.00007545773,0.001031206,0.001881064,0.000356244,0.001489664,0.006545539,0.00008703289,0.002449597,0.00006330382],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977201,0.001602252,0.0001380332,0.00005814046,0.00001282016,0.00004118096,0.00008276817,0.000007038253,0.0003377147],"genre_scores_gemma":[0.9987386,0.000506275,0.0001910605,0.0001349458,0.00007806435,0.00005059593,0.0001567095,0.000002524444,0.0001412369],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009604082,"threshold_uncertainty_score":0.004565001,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02495858391310683,"score_gpt":0.3546411885409498,"score_spread":0.3296826046278429,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}